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Abstract 
Introduction 
• Depression is a common and debilitating disorder.  It is complicated 
by a variety of presentations and patient compliance.  There are many 
treatment options available, including pharmacotherapy, cognitive 
behavioral therapy, and somatic therapy.  The purpose of this study is 
to explore the various treatment options and their effectiveness.  Our 
primary focus will be severe, treatment resistant depression and the 
options available for treatment.   
Research Questions 
Literature Review Applicability to Clinical 
Practice 
Acknowledgements  
• Treatment of depression is highly variable based on specific patient 
presentation.  
• In adults with depression, where pharmacotherapy or CBT is 
indicated, which is the better method of treatment? 
– A comparison of CBT versus pharmacotherapy was seen in a study done 
by Siddique et al. (2012) demonstrating the benefits and drawbacks of 
both among low-income minority women.  This study showed similar 
results while receiving therapy, but better long-term results in the CBT 
group while not receiving active treatment.   
– According to current practice guidelines supported by the APA, either 
pharmacotherapy or CBT are appropriate lines of therapy for mild to 
moderate depression as first-line therapy. (Gelenberb et al., 2010). 
• In adults with severe, treatment resistant depression, is 
Electroconvulsive Therapy a better treatment option than 
medications, for management of symptoms? 
– According to an article published in the American Journal of Psychiatry, 
ECT is primarily used in treatment of depression that is resistant to 
medication therapy.  However, initial treatment with ECT should be 
given primary consideration when there are extenuating circumstances 
present.  In patients with suicidal ideation, failure to have proper oral 
intake, weight loss, and psychosis with agitation (Kellner et al., 2012).  
• In treatment of severe depression with ECT, does the use of 
concurrent pharmacotherapy and/or cognitive behavioral therapy 
improve patient outcomes? 
– A study published by the Society of Biological Psychiatry evaluated 
continuing treatment options for patients who responded to treatment 
with ECT to achieve sustained remission. The results of this study 
demonstrated the best results with medication and CBT, with significant 
response sustained twelve months later (Brakemeier et al., 2013).   
• In the treatment of severe, treatment resistant depression, are 
there safer alternatives to Electroconvulsive Therapy? 
– According to current practice guidelines, rTMS is FDA approved, but 
studies have reported mixed results.  Given the low side effect profile, it 
may be considered for use and may have benefit (Gelenberb et al., 2010). 
– When compared with ECT, which has substantial supporting evidence of 
benefit, the mixed results of rTMS is rather disappointing.   
• Depression is a common and debilitating disease complicated by 
comorbidities, medication side effects, limited alternative treatment 
options, and poor patient adherence.  
• Currently, clinical practice guidelines are available outlining the 
indications and treatment options for depression.  
• Discussion will involve pathophysiology of the disease process and 
possible treatments, such as pharmacotherapy, cognitive behavioral 
therapy and somatic therapy, including electroconvulsive therapy 
(ECT).   
• ECT is widely accepted as an effective treatment for severe refractory 
depression, but has a negative social stigma despite its effectiveness.   
• This paper has shown ECT remains the most effective treatment of 
severe refractory depression in adult patients, despite the negative 
reputation it holds.   
• Repetitive Transcranial Magnetic Stimulation (rTMS) will be also be 
discussed as a possible alternative to established methods of 
treatment.   
• In adults with depression, where pharmacotherapy or CBT is 
indicated, which is the better method of treatment? 
• In adults with severe, treatment resistant depression, is 
Electroconvulsive Therapy a better treatment option than medications 
for management of symptoms? 
• In treatment of severe depression with Electroconvulsive Therapy, 
does the use of concurrent pharmacotherapy and/or cognitive 
behavioral therapy improve patient outcomes? 
• In the treatment of severe, treatment resistant depression, are there 
safer alternatives to Electroconvulsive Therapy? 
• Occurring when sadness becomes uncontrollable, depression 
commonly presents with difficulty sleeping and fatigue, decreased 
appetite, weight loss, decreased interest in personal relationships, and 
loss of interest in activities thought to be pleasurable (McCance, 
Huether, Brashers, & Rote, 2010). 
• Depression is believed to occur because of a decrease in 
norepinephrine, dopamine, and/or serotonin levels in the brain.  
Medications work to correct these imbalances (McCance et al., 2010).  
• According to clinical practice guidelines, there is equal efficacy 
amongst the classes of antidepressants, but not all antidepressants 
should be used equally or for every patient (Gelenberb et al., 2010). 
– When comparing SSRIs to TCAs, both classes were equally efficacious 
(BR=1.01; 95% CI:  0.84-1.21; p=0.91), however, SSRIs had fewer 
adverse effects (OR=0.48; 95% CI:  0.32-0.70; p<0.001) and lower 
dropout rates (OR=0.41; 95% CI:  0.19-0.86; p=0.02) than TCAs (von 
Wolff, Holzel, Westphal, Harter, & Kriston, 2013). 
• There are better long-term treatment outcomes for patients who 
received CBT than for patients treated with 6 months of 
pharmacotherapy.  
– During the time patients were actively receiving therapy, CBT or 
medication, Hamilton Depression Rating scale (HDRS) scores were 
similar among the groups (Siddique, Chung, Brown, & Miranda, 
2012).   
• According to current practice guidelines, ECT is recommended for the 
treatment of severe, major depressive disorder that is not improved by 
pharmacotherapy or psychotherapy.  (Gelenberb et al., 2010). 
– In one study, prior to treatment with ECT, the sample group had worse 
scores on all eight scales (p<0.0001) prior to treatment.  After treatment, 
health related quality of life scores were not significantly different 
between the patients who sustained remission after treatment with ECT 
and the normal control group (McCall et al., 2013). 
• ECT is felt to be the most effective method of treatment for severe, 
treatment resistant depression.  However, using adjunctive 
pharmacotherapy and CBT should be utilized after remission is 
achieved. (Brakemeier et al., 2014). 
• Repetitive transcranial magnetic stimulation (rTMS) has been studied 
as an alternative for the treatment of depression.  However, studies 
show mixed treatment plans and results (Gelenberb et al., 2010). 
• A systematic review done on rTMS demonstrated a small 
antidepressant effect when used for treatment of non-refractory 
depression. 
– The Clinical Global Impressions (CGI) reduction due to rTMS is 
considered only a minimal reduction when measured on the CGI scale 
and routine use of rTMS is questionable (Lepping et al., 2014).   
 
 
• For treatment of mild to moderate severity depression, the options are 
well-studied and clinical practice guidelines should be consulted.  
– Either pharmacotherapy or CBT are reasonable options and should be 
discussed with each individual patient.  
– Side effect profiles of the medications being considered should determine 
which medication may be more appropriate for the situation.  
• For patients with severe depression or specific indications for use, 
ECT should be considered. 
– Patients with severe depression with psychosis, catatonia, or need for 
immediate benefit should necessitate a conversation about ECT. 
• An important consideration when deciding on an appropriate 
treatment method is specific patient presentation and patient 
preferences. 
– There are so many different presentations on the depression spectrum and 
so many variables that contribute to severity.  
Statement of the Problem 
• There are many interventions available for the treatment of 
depression.  However, treatment of depression can complicated 
by many factors including non-compliance, treatment resistant 
symptoms, negative social perceptions of treatment, and 
common co-morbidities.   
Discussion 
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